A recent study identifies a hypoxia induced senescent cancer associated fibroblast (hsCAF) subpopulation that promotes ESCC stemness and chemoresistance via IGF1 signaling, highlighting hsCAFs as a potential therapeutic target (Ou et al., 2025). The gene discussed is IGF1; the disease is cancer.